多聚腺苷酸二磷酸核糖转移酶抑制剂的放射增敏作用及机制研究
摘要
放疗是恶性肿瘤的主要治疗手段之一，临床上约70％的恶性肿瘤患者在治疗不同阶段需接受放疗。多种细胞毒药物被用于放疗联合治疗以增加对肿瘤的治疗疗效，如氟尿嘧啶、顺铂、卡铂和丝链霉素C等，然而它们往往在增加肿瘤细胞杀伤的同时也加重了正常组织损伤，因此寻找特异性针对肿瘤的放射增敏剂是放疗研究的方向。
出处
《中华放射肿瘤学杂志》
CSCD
北大核心
2012年第4期380-383,共4页
Chinese Journal of Radiation Oncology
基金
国家自然科学基金项目（81072164）
参考文献31
-
1Chalmers AJ,Lakshman M,Chan N. Poly (ADP-ribose)polymerase inhibition as a model for synthetic lethality in developing radiation oncology targets[J].Seminars in Radiation Oncology,2010.274-281.
-
2Meyn RE,Munshi A,Haymach JV. Receptor signaling as a regulatory mechanism of DNA repair[J].Radiotherapy and Oncology,2009.316-322.
-
3Jorgensen TJ. Enhancing radiosensitivity:targeting the DNA repair pathways[J].Cancer Biology and Therapy,2009.665-670.
-
4Femet M,Hall J. Genetic biomarkers of therapeutic radiation sensitivity[J].Dna Repair,2004.1237-1243.
-
5Powell C,Mikropoulos C,Kaye SB. Pre-clinical and clinical evaluation of PARP inhibitors as tumour-specific radiosensitisers[J].Cancer Treatment Reviews,2010.566-575.
-
6Leung M,Rosen D,Fields S. Poly(ADP-ribose) polymerase-1 Inhibition:preclinical and clinical development of synthetic lethality[J].Molecular Medicine,2011.
-
7Drew Y,Plummer R. The emerging potential of poly(ADP-ribose)polymerase inhibitors in the treatment of breast cancer[J].Current Opinion in Obstetrics and Gynecology,2010.67-71.
-
8Tutt A,Robson M,Garber JE. Oral poly (ADP-ribose)polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer:a proof-of-concept trial[J].The Lancet,2010.235-244.
-
9Calabrese CR,Almassy R,Barton S. Anticancer chemosensitization and radiosensitization by the novel poly (ADP-ribose) polymerase-1 inhibitor AG14361[J].Journal of the National Cancer Institute,2004.56-67.
-
10Albert JM,Cao C,Kim KW. Inhibition of poly(ADPribose)polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models[J].Clinical Cancer Research,2007.3033-3042.
-
1李慧兰,李帅,翟丽丽,付丽.PARP1及其活性产物PAR在三阴性乳腺癌中的表达及意义[J].中国肿瘤临床,2014,41(24):1564-1567. 被引量：1
-
2秦东媛,师水生.甲基化转移酶抑制剂和紫杉醇对低分化胃癌细胞株的作用[J].胃肠病学和肝病学杂志,2009,18(3):269-272. 被引量：1
-
3金紫凝.PARP-1在乳腺癌中的表达[J].中国实用乡村医生杂志,2014(16):18-19.
-
4黄淑晶,王希成.放射治疗对肿瘤患者免疫功能的影响[J].临床医学工程,2012,19(1):151-154. 被引量：6
-
5王哲,李燕,吕树卿,田永杰.PARP-1与NF-κB在卵巢上皮性肿瘤组织中的表达及意义[J].实用妇产科杂志,2013,29(9):676-679. 被引量：5
-
6彭大鹏,米瑞华,范瑞华,尹青松,汪小姣,魏旭东.干扰素联合沙利度胺对B细胞淋巴瘤细胞株OCI-LY7细胞的作用及其机制研究[J].中华血液学杂志,2017,38(4):343-346. 被引量：4
-
7吕树卿,尉蔚,张灿灿,田永杰.HGF/PARP-1信号通路调控卵巢癌细胞侵袭转移的作用[J].山东大学学报（医学版）,2015,53(7):1-7. 被引量：4
-
8胡淑贤,李冬梅,石搏,黄可欣.心理护理对老年乳腺癌化疗患者血清PARP-1和Caspase-3蛋白表达水平的影响[J].中国老年学杂志,2013,33(5):1014-1015. 被引量：16
-
9余佳,金浩,陈辰,王卫星,邓文宏,陈晓燕,陈颖.聚ADP核糖聚合酶抑制剂对重症急性胰腺炎大鼠肺炎症介质表达和肺损伤的影响[J].中华急诊医学杂志,2012,21(1):38-42. 被引量：7
-
10于月成,吴维光.5-脱氧杂氮胞苷调控p16基因表达对人宫颈癌HeLa细胞增殖及调亡的影响[J].西北国防医学杂志,2012,33(2):110-113. 被引量：1
